The Commission says this clause (13.1e) in AstraZeneca’s EU contract would make any preferential treatment for UK a violation.

It says AZ is not under any other contract obligation (for instance, to UK) that would impede fulfilment of its obligations to the EU.
Lots of other interesting bits in this Article.

Some fascinating details about Hancock’s insistence Oxford partner with a British company, and also how his foresight to solve distribution logistics issues well before a vaccine was ready has been a key to the UK’s early success.
You can follow @DaveKeating.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.